Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004
Intake of n -3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021
The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021
The role of partially hydrolysed formulae, probiotics and omega-3 fatty acids in cow‘s milk allergy in children Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009
Intake of antioxidants and n-3 and n-6 PUFA in relation to asthma and eczema in a cohort of pregnant women Source: Eur Respir J 2002; 20: Suppl. 38, 428s Year: 2002
Prenatal polyunsaturated fatty acid exposure is associated with childhood atopy and wheeze Source: Annual Congress 2010 - Paediatric epidemiology Year: 2010
Polyunsaturated fatty acids in maternal diet and maternal and cord blood in relation to atopic dermatitis in children Source: Eur Respir J 2004; 24: Suppl. 48, 161s Year: 2004
Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007
An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001
Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007
Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010
Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
The effect of dietary fatty acids on respiratory infection in human lung cells Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018
Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Airway inflammation is augmented by obesity and fatty acids in asthma Source: Eur Respir J 2011; 38: 594-602 Year: 2011